Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for

Xiufeng Liu1, Yinying Lu2, Weiping Zhou3

  • 1Department of Medical Oncology of PLA Cancer Center, Jinling Hospital, Nanjing, China.

Liver Cancer
|August 8, 2024
PubMed
Abstract

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K